drugset / Trial / NCT03851731
Evaluation of Intranasal Naltrexone and Naloxone
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will be to determine the pharmacokinetics of naltrexone and naloxone when administered via intranasal separately and in combination in healthy volunteers.
Timeline
- Start
- 2015-10-05
- Primary completion
- 2015-11-07
- Completion
- 2015-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | 4 mg | Intranasal |
| Subject | Naltrexone | Small molecule | 2 mg | Intranasal |